How does Medicare cover and reimburse anti-cancer drugs administered for an off-label indication?
Medicare covers off-label uses of anti-cancer drugs if the drug’s indication is listed as “accepted” in the following compendium; AHFS, NCCN, Clinical Pharmacology and DrugDex or if there is data in CMS accepted peer-reviewed articles in the journals. Please contact ABRAXANE’s Medical Information (ARC of Support, Option 2) if you wish to request a copy of ABRAXANE clinical literature. Please request the data by its’ title.
